Synonyms: | |
Status: | Phase 2 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | BPD4DGQ314 |
Primary Target | |
---|---|
CD20 (membrane-spanning 4-domains, subfamily A, member 1) |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Purpura, Thrombocytopenic, Idiopathic | 1 | D016553 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Waldenstrom Macroglobulinemia | 1 | D008258 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 728917-18-8 |
ChEMBL | CHEMBL1743088 |
FDA SRS | BPD4DGQ314 |
Guide to Pharmacology | 8268 |